NeoPharm CO. LTD Free Cash Flow Generation Index
NeoPharm CO. LTD free cash flow generation index. NeoPharm CO. LTD (092730) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩5.43 Billion represents 1% of operating cash flow (₩5.88 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of NeoPharm CO. LTD (2012–2024)
Free cash flow generation index of NeoPharm CO. LTD from 2012 to 2024. Historical FCF Generation Index trend for NeoPharm CO. LTD across 11 annual periods. See how financially flexible is NeoPharm CO. LTD to measure the company's free cash flow as a share of total liabilities.
NeoPharm CO. LTD Free Cash Flow Generation Index by Year (2012–2024)
NeoPharm CO. LTD free cash flow generation index by year from 2012 to 2024. Year-by-year Free Cash Flow Generation Index for NeoPharm CO. LTD. For the full cash flow conversion analysis, see 092730 cash flow metrics.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.83x | ₩15.55 Billion | ₩18.63 Billion | ₩3.08 Billion | ▲ +697.6% |
| 2023 | 0.10x | ₩2.43 Billion | ₩23.26 Billion | ₩20.83 Billion | ▼ -89.0% |
| 2022 | 0.96x | ₩17.35 Billion | ₩18.16 Billion | ₩806.43 Million | ▼ -2.3% |
| 2021 | 0.98x | ₩21.20 Billion | ₩21.68 Billion | ₩320.11 Million | ▲ +2.2% |
| 2020 | 0.96x | ₩16.34 Billion | ₩17.07 Billion | ₩285.62 Million | ▼ -17.5% |
| 2019 | 1.16x | ₩22.31 Billion | ₩19.22 Billion | ₩5.90 Billion | ▲ +3.6% |
| 2018 | 1.12x | ₩18.12 Billion | ₩16.18 Billion | ₩1.94 Billion | ▲ +3.4% |
| 2017 | 1.08x | ₩11.53 Billion | ₩10.65 Billion | ₩884.71 Million | ▼ -6.1% |
| 2016 | 1.15x | ₩10.56 Billion | ₩9.16 Billion | ₩1.40 Billion | ▲ +2.2% |
| 2015 | 1.13x | ₩6.88 Billion | ₩6.09 Billion | ₩786.89 Million | ▼ -13.5% |
| 2012 | 1.31x | ₩736.81 Million | ₩564.34 Million | ₩172.47 Million | — |